GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orthocell Ltd (ASX:OCC) » Definitions » Dividend-Payout-to-FFO

Orthocell (ASX:OCC) Dividend-Payout-to-FFO


View and export this data going back to 2014. Start your Free Trial

What is Orthocell Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Orthocell (ASX:OCC) Business Description

Traded in Other Exchanges
N/A
Address
90 South Street, Building 191, Murdoch University, Murdoch, Perth, WA, AUS, 6150
Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialisation of cell therapies and related technologies. Its product includes CelGro is a naturally derived collagen medical device for tissue repair and Ortho-ATI is a first-in-class cell therapy for the treatment of chronic tendon injuries.